HOME

ABOUT PCSS

PCSS MENTORS

ADMIN LOGIN

MENTOR LOGIN

 

PCSS Clinical Guidances

(click on links to download document)

 

PCSS Guidance: Acute Pain

 

PCSS Guidance: Management of Psychiatric Medications in Patients Receiving Buprenorphine/Naloxone

 

PCSS Guidance: Monitoring of Liver Function Tests and Hepatitis in Patients Receiving Buprenorphine/Naloxone

 

PCSS Guidance: Opioid Therapies, HIV Disease and Drug Interactions UPDATED

 

PCSS Guidance: Physician Billing For Office-Based Treatment of Opioid Dependence

 

PCSS Guidance: Pregnancy and Buprenorphine Treatment

 

PCSS Guidance: Transfer from Methadone to Buprenorphine

 

PCSS Guidance: Psychosocial Aspects of Treatment in Patients Receiving Buprenorphine/Naloxone  NEW

 

Disclaimer for PCSS Clinical Guidances
The PCSS Clinical Guidances have been developed as a resource for interested physicians, but the PCSS program is only a vehicle for the sharing of knowledge and information; it is not a referral mechanism. While it is expected that inquiries presented to mentoring physicians will be based on fact patterns related to actual cases, remarks and opinions from mentoring physicians should be understood as being general in nature and not directed at a specific patient or case. Opinions and counsel from a mentor should not be used as a substitute for the opinion, judgment, and knowledge of the treating physician. No physician-patient or other relationship, expressed or implied, is created between a mentoring physician and any patient by virtue of participation in the PCSS program.  

 

page updated 5/23/07